These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9528964)

  • 1. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2.
    Weyman CM; Wolfman A
    Endocrinology; 1998 Apr; 139(4):1794-800. PubMed ID: 9528964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of mitogen-activated protein kinase in response to basic fibroblast growth factor in skeletal muscle cells.
    Campbell JS; Wenderoth MP; Hauschka SD; Krebs EG
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):870-4. PubMed ID: 7846069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways.
    Milasincic DJ; Calera MR; Farmer SR; Pilch PF
    Mol Cell Biol; 1996 Nov; 16(11):5964-73. PubMed ID: 8887626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras.
    Weyman CM; Ramocki MB; Taparowsky EJ; Wolfman A
    Oncogene; 1997 Feb; 14(6):697-704. PubMed ID: 9038377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.
    Lassarre C; Ricort JM
    Endocrinology; 2003 Nov; 144(11):4811-9. PubMed ID: 12960057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase.
    Gardner AM; Johnson GL
    J Biol Chem; 1996 Jun; 271(24):14560-6. PubMed ID: 8662985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
    Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
    J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts.
    Samuel DS; Ewton DZ; Coolican SA; Petley TD; McWade FJ; Florini JR
    Horm Metab Res; 1999; 31(2-3):55-64. PubMed ID: 10226782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD98059 enhances C2 myoblast differentiation through p38 MAPK activation: a novel role for PD98059.
    Al-Shanti N; Stewart CE
    J Endocrinol; 2008 Jul; 198(1):243-52. PubMed ID: 18467380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation.
    Maher P
    J Biol Chem; 1999 Jun; 274(25):17491-8. PubMed ID: 10364180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation.
    Sarbassov DD; Peterson CA
    Mol Endocrinol; 1998 Dec; 12(12):1870-8. PubMed ID: 9849961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion.
    Jones NC; Fedorov YV; Rosenthal RS; Olwin BB
    J Cell Physiol; 2001 Jan; 186(1):104-15. PubMed ID: 11147804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor (IGF)-binding protein-related protein-1: an autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF.
    Haugk KL; Wilson HM; Swisshelm K; Quinn LS
    Endocrinology; 2000 Jan; 141(1):100-10. PubMed ID: 10614628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p42/p44 mitogen-activated protein kinases activation is required for the insulin-like growth factor-I/insulin induced proliferation, but inhibits differentiation, in rat fetal brown adipocytes.
    Porras A; Alvarez AM; Valladares A; Benito M
    Mol Endocrinol; 1998 Jun; 12(6):825-34. PubMed ID: 9626658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of urokinase-type plasminogen activator expression by basic fibroblast growth factor and serum in myogenesis. Requirement of a common mitogen-activated protein kinase pathway.
    Miralles F; Ron D; Baiget M; Félez J; Muñoz-Cánoves P
    J Biol Chem; 1998 Jan; 273(4):2052-8. PubMed ID: 9442043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts.
    Sarbassov DD; Jones LG; Peterson CA
    Mol Endocrinol; 1997 Dec; 11(13):2038-47. PubMed ID: 9415407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation.
    Adi S; Bin-Abbas B; Wu NY; Rosenthal SM
    Endocrinology; 2002 Feb; 143(2):511-6. PubMed ID: 11796505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes.
    Zeigler ME; Chi Y; Schmidt T; Varani J
    J Cell Physiol; 1999 Aug; 180(2):271-84. PubMed ID: 10395297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.